The content on this site is intended for healthcare professionals only
Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
18 Oct 2021
Healthcare delivery for non-communicable diseases among breast cancer survivors ...
Dr Sanjeeva Gunasekera - National Cancer Institute, Maharagama, Sri Lanka
12 Oct 2021
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastati...
Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain
30 Sep 2021
ESMO 2021: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
27 Sep 2021
[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally a...
Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain
![[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metastatic breast cancer ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )](https://cdn.ecancer.org/42950-m.jpg "[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metastatic breast cancer ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )")
24 Sep 2021
Assessment of guideline adherence in breast cancer management among oncologists ...
Dr Bolanle Adegboyega - Lagos University Teaching Hospital, Lagos, Nigeria
23 Sep 2021
ESMO 2021 Roundup
Dr Bishal Gyawali - Queen's University, Kingston, Canada
22 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
21 Sep 2021
Giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausa...
Dr Sara Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
20 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 4
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
20 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 3
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
19 Sep 2021
First-line CDK 4/6 inhibition shows OS benefit for metastatic breast cancer
Prof Gabriel Hortobagyi - The University of Texas MD Anderson Cancer Center, Hou...
19 Sep 2021
